GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect-Reference-Cited by-同舟云学术

GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect

Published:2022-11-22 Issue:1 Volume:20 Page:663-679
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Priya Vishnu¹,Singh Sanjeev K.²,Revand Ravindran²,Kumar Sandip³,Mehata Abhishesh Kumar¹,Sushmitha Paulraj⁴,Mahto Sanjeev Kumar⁴^ORCID,Muthu Madaswamy S.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Engineering and Technology, IIT (BHU), Varanasi221005, UP, India

2. Department of Physiology, IMS, Banaras Hindu University, Varanasi221005, India

3. Department of Pathology, IMS, Banaras Hindu University, Varanasi221005, India

4. School of Biomedical Engineering, IIT (BHU), Varanasi221005, UPIndia

Funder

Ministry of Human Resource Development

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00848

Reference61 articles.

1. World Health Organization. Cardiovascular diseases (CVDs). June 11, 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed July 5, 2022).

2. World Health Organization. Top 10 causes of death. December 9, 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed July 5, 2022).

3. Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase

4. Rutin- potent natural thrombolytic agent

5. Thrombus-Targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine hydrochloride-loaded lipid-based nanoparticles ameliorate β-cell function by targeting Nrf2/NF-κB signaling pathway in alloxan-induced diabetes using a murine model: Optimization through full factorial design;Journal of Drug Delivery Science and Technology;2024-10

2. Lipid-Based Carriers for Targeting Lymphatic System;Advanced Targeting of the Lymphatic System;2024

3. Nattokinase Encapsulated Nanomedicine for Targeted Thrombolysis: Development, Improved in Vivo Thrombolytic Effects, and Ultrasound/Photoacoustic Imaging;Molecular Pharmaceutics;2023-12-21

4. Fabrication, in-silico, in-vitro, and in-vivo characterization of transferrin-targeted micelles containing cisplatin and gadolinium for improved theranostic applications in lung cancer therapy;European Journal of Pharmaceutics and Biopharmaceutics;2023-12

5. EGFR targeted albumin nanoparticles of oleanolic acid: In silico screening of nanocarrier, cytotoxicity and pharmacokinetics for lung cancer therapy;International Journal of Biological Macromolecules;2023-08